Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Wearable Sensors and Video-Based Testing to Track Arm Function After Treatment for Neurogenic Thoracic Outlet Syndrome

13 novembre 2026 aggiornato da: Bryan M. Burt, MD, FACS, University of California, Los Angeles

Remote Assessment and Digital Biomarker-Based Testing for Neurogenic Thoracic Outlet Syndrome: Longitudinal Follow-up After Physical Therapy or Surgery (Study 2)

The goal of this study is to learn whether wearable motion sensors and video-based movement analysis can track changes in arm function over time in adults with neurogenic thoracic outlet syndrome (NTOS) who are receiving standard treatment (physical therapy or surgery).

NTOS happens when nerves between the neck and shoulder are squeezed, causing pain, numbness, weakness, and trouble using the arm. There is currently no objective test to measure how severe NTOS is or how well treatment is working.

The main questions this study aims to answer are:

  • Can digital measurements of arm movement, collected with wearable sensors and with standard webcam video, detect changes in arm function after NTOS treatment?
  • Are these digital measurements more sensitive to change than standard questionnaires?
  • Do video-based measurements agree with sensor-based measurements?
  • Can measurements taken before treatment help predict who will improve with physical therapy?

This study does not assign or change treatment. Physical therapy or surgery is chosen by each participant's doctors as part of usual care.

Participants will:

  • Complete 5 study visits over about 12 months: before treatment and 1 and 2 months after treatment (in clinic), and 6 and 12 months after treatment (remote telemedicine visits)
  • At each visit, perform a short arm movement task (the "Press Test," a 20-second hand-over-head exercise) while wearing motion sensors and/or being recorded on video
  • Complete questionnaires about arm function, pain, mood, and overall health

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Descrizione dettagliata

Neurogenic thoracic outlet syndrome (NTOS) is a disorder of dynamic compression of the brachial plexus between the first rib and the scalene muscles. Diagnosis currently relies on subjective clinical assessment, and there are no objective measures to monitor response to treatment. This study evaluates a remote patient monitoring platform that extracts digital biomarkers of upper extremity motor function from the Press Test, a 20-second repetitive hand-over-head task designed to provoke NTOS symptoms.

This is a single-site, prospective longitudinal study at the UCLA Thoracic Outlet Syndrome Center. Adults with a treating-physician diagnosis of NTOS who are proceeding with standard-of-care treatment (physical therapy and/or surgery) are followed for 12 months. Treatment selection is made by the treating clinicians and is not assigned by the study. Approximately 50 participants undergoing physical therapy and 50 undergoing surgery will be enrolled.

At each of five time points (baseline 0-1 month before treatment; 1, 2, 6, and 12 months after treatment), participants perform the Press Test while digital biomarkers are captured with wearable inertial sensors and with AI-based analysis of standard webcam video. The baseline, 1-month, and 2-month assessments are performed in person; the 6- and 12-month assessments are performed remotely via secure telehealth, with sensors provided in clinic or mailed to the participant with written instructions and staff support. Patient-reported outcomes (DASH, VAS pain, Zung Self-Rating Depression Scale, and PROMIS Global Health) are collected at each time point. Feasibility and acceptability of remote assessment are evaluated through visit completion rates, time burden, technical issues, and a technology acceptance questionnaire.

Analyses will use linear and generalized linear mixed models to assess change over time, intraclass correlation coefficients and Bland-Altman analyses to compare sensor- and video-derived measures, and exploratory models to identify baseline predictors of response to physical therapy.

This study is funded by the National Institutes of Health (R01HD121303).

Tipo di studio

Osservativo

Iscrizione (Stimato)

100

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

Da 18 anni a 60 anni (Adulto)

Accetta volontari sani

N/A

Sessi ammissibili allo studio

Tutto

Metodo di campionamento

Campione non probabilistico

Popolazione di studio

Adults aged 18 to 60 years with a treating-physician diagnosis of neurogenic thoracic outlet syndrome who are evaluated at the UCLA Thoracic Outlet Syndrome Center and are proceeding with standard-of-care physical therapy or surgery.

Descrizione

Inclusion Criteria:

  • Men or women aged 18 to 60 years
  • Treating-physician diagnosis of neurogenic thoracic outlet syndrome (NTOS)
  • Plan for standard-of-care treatment (physical therapy and/or surgery) at UCLA
  • Right-handed, left-handed, or ambidextrous
  • Able to provide informed consent and complete study activities

Exclusion Criteria:

  • Bilateral NTOS
  • Previous surgery for NTOS at any time, or NTOS-directed physical therapy within the past 2 months
  • Venous thoracic outlet syndrome
  • Arterial thoracic outlet syndrome
  • NTOS together with another condition affecting the upper extremity
  • Cognitive impairment
  • Acute or chronic conditions unrelated to NTOS that may affect upper extremity function (e.g., stroke, Parkinson's disease, arthritis, cancer)
  • History of drug or alcohol abuse within the past 6 months
  • Inability to participate in follow-up assessments (e.g., plans to move out of state within 12 months, or inability to complete remote follow-up visits)

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Modelli osservazionali: COHORT
  • Prospettive temporali: PROSPECTIVE

Coorti e interventi

Gruppo / Coorte
Physical Therapy

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care physical therapy. Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

Surgery

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care surgical decompression (e.g., first rib resection, scalenectomy, and brachial plexus neurolysis). Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Press Test Digital Biomarkers of Upper Extremity Function
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Digital biomarkers of upper extremity motor function (representing slowness, weakness, rigidity, exhaustion, and unsteadiness, e.g., speed, power, rise time, and range of motion) extracted from a 20-second repetitive hand-over-head Press Test using wearable inertial sensors and AI-based webcam video analysis. Change from baseline will be assessed at each follow-up time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

The DASH is a 30-item self-reported questionnaire of upper extremity disability and symptoms. Scores range from 0 to 100; higher scores indicate greater disability.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Change in Pain Intensity (Visual Analog Scale)
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Self-reported pain intensity on a 0 to 10 visual analog scale; higher scores indicate worse pain.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Zung Self-Rating Depression Scale (SDS) Score
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

20-item self-reported depression scale. Raw scores range from 20 to 80; higher scores indicate more severe depressive symptoms.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in PROMIS Global Health Physical and Mental Health T-Scores
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

PROMIS Global Health v1.2 (10 items) yields Global Physical Health and Global Mental Health T-scores (population mean 50, SD 10); higher scores indicate better health.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Agreement Between Sensor-Based and Video-Based Digital Biomarkers
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Agreement between digital biomarkers derived from wearable sensors and from AI-based webcam video analysis during the Press Test, assessed by intraclass correlation coefficient (ICC) at each time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Baseline Digital Biomarkers as Predictors of Response to Physical Therapy
Lasso di tempo: Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Performance of machine learning models using pre-treatment digital biomarkers, demographics, and clinical factors to predict non-response to physical therapy (no meaningful symptom improvement), reported as area under the ROC curve (AUC).

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

20 novembre 2026

Completamento primario (Stimato)

1 novembre 2030

Completamento dello studio (Stimato)

1 novembre 2031

Date di iscrizione allo studio

Primo inviato

13 novembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 novembre 2026

Primo Inserito (Effettivo)

19 novembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

19 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • IRB-26-0380-Study2
  • R01HD121303 (Sovvenzione/contratto NIH degli Stati Uniti)

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .